Lab Group Developments!
- Christos Hatzis, the co-founder of NuverBiosciences, has co-developed the Residual Cancer Burden metric after neoadjuvant chemotherapy.
- Weiwei Shi has developed an online visualization tool to interpret complex genomic abnormalities in the context of biological pathways.
Events
Copy Link
Lab Meetings
Copy Link
- The Bioinformatics group lab meeting is held on Wednesdays at 3PM in 300 George Street, Suite 120, Room 133.
- The Breast Cancer Translational Research lab meeting is held at the same location on Thursdays at 4PM.